Condensed Consolidated Balance Sheets - USD ($) $ in Thousands		Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash		$ 13,764	$ 9,483
Trade accounts receivable, net		419	421
Receivable research incentives		183	4,774
Inventories		2,533	2,114
Prepaid expenses and other current assets		4,545	1,116
Deferred offering costs		0	1,250
Total current assets		21,444	19,158
Property and equipment, net		2,537	3,249
Operating lease right-of-use assets		8,066	8,578
Intangible assets, net		262	272
Other noncurrent assets		1,345	1,353
Total assets		33,654	32,610
Current liabilities:
Trade accounts payable		2,487	2,109
Accrued expenses and other current liabilities		5,318	3,614
Current portion of operating lease liabilities		1,461	1,687
Current portion of long term debt, net		2,232	220
Deferred revenue, current		1,668	2,665
Promissory note - related party		420	0
Total current liabilities		13,586	10,295
Warrant liabilities		5,498	0
Operating lease liabilities, net of current portion		6,211	6,990
Loans payable, noncurrent		12,626	12,233
Deferred revenue, noncurrent		0	54
Other noncurrent liabilities		0	18
Total liabilities		37,921	29,590
Commitments and contingencies (Note 12)
Stockholders' (deficit) equity:
Non-redeemable convertible preferred stock*, no par value; nil shares and 122,564,333 shares authorized as of September 30, 2022 and December 31, 2021, respectively; nil shares and 122,564,333 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively.	[1]	0	189,881
Common stock*, par value $0.0001 per share; 675,000,000 shares and unlimited shares authorized at September 30, 2022 and December 31, 2021, respectively; 110,377,357 shares and 2,817,498 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively.	[1]	11	0
Additional paid-in capital		370,155	148,850
Accumulated deficit		(364,008)	(325,268)
Accumulated other comprehensive loss		(10,425)	(10,443)
Total stockholders' (deficit) equity		(4,267)	3,020
Total liabilities and stockholders' equity		$ 33,654	$ 32,610

[1] Shares of legacy non-redeemable convertible preferred stock and legacy common stock have been retroactively restated to give effect to the Merger.